Available Dates
April 8-12, 2026 | Charlotte, NC
Abstracts
Abstracts
Abstracts
Share Your Cutting-Edge Research as a Poster at SAWC Spring WHS 2026
The Symposium on Advanced Wound Care (SAWC) WHS Spring 2026 invites you to submit an abstract for consideration to be presented as a poster at the Charlotte Convention Center in Charlotte, NC, April 8-April 12, 2026. This is your opportunity to share your cutting-edge research with the best-in-class audience of experts in the field.
Posters will be on display during all poster hall hours and on multimedia screens. ePosters will also be available to view in the mobile app.
The Symposium on Advanced Wound Care (SAWC) WHS Spring 2026 invites you to submit an abstract for consideration to be presented as a poster at the Charlotte Convention Center in Charlotte, NC, April 8-April 12, 2026. This is your opportunity to share your cutting-edge research with the best-in-class audience of experts in the field.
Posters will be on display during all poster hall hours and on multimedia screens. ePosters will also be available to view in the mobile app.
SAWC Spring | WHS 2026 Abstract Overview
Abstracts are brief summaries of the overall goal of an offering and the specific ideas or concepts that will be presented, including outcomes and implications for practice. Limit abstracts to a 250-to-350-word count and divide it into the following sections: introduction, methods, results, and discussion. An in-depth overview of the SAWC Spring | WHS 2026 Abstract Guidelines can be viewed here.
Key Dates* for Abstract Submissions
- Abstract Submission Site Opens – Tuesday, August 12, 2025
- Abstract Submission Site Closes – Friday, December 12, 2025
- Notification of Acceptance or Rejection – Wednesday, January 28, 2026
- Registration and Intent to Present Due – Wednesday, February 11, 2026
- PDF Posters Due – Wednesday, March 11, 2026
*Deadlines are tentative and subject to change
Abstracts submitted by December 12, 2025, may be eligible for the following benefits and/or awards that correspond to the selected abstract presentation categories indicated by the abstract submitter during the submission process:
- ePoster Display (digital poster PDF)
- Poster Hall Poster Display (printed poster)
- First-to-Podium Abstract presentation
- Marie Brown Etris Oral Abstract Awards
- Highest Scoring Abstract Awards (by Submission Category)
- Young Investigator Award
- RAPID FIRE: Poster Talks
- Tuition Support ($50 off registration fee for submitter)
- Publishing opportunities in supplement of Wounds
Abstract Presentation Categories
1. First-to-Podium Presentation Only
The First-to-Podium Presentation category is reserved exclusively for work that is being presented for the first time. Only truly original, practice-enhancing research, emerging data, or novel innovations that have not been presented, published, posted, or shared in any scientific, educational, or public forum are eligible for consideration.
To maintain the integrity of this high-visibility category and to respect the valuable time and expertise of our clinician reviewers, the following requirements will be enforced:
- Submissions must represent new and unpublished work.
- Content must not have been previously presented at any conference, symposium, webinar, or event etc.
- Content must not have been published in any journal, digital platform, or similar outlet.
- Submissions should include novel insights or innovative approaches with the potential to change or significantly enhance clinical practice.
Any submission entered into the First-to-Podium category that does not meet all eligibility criteria will be declined without an opportunity to resubmit.
This policy ensures fairness in the review process and upholds the standard of excellence expected by the conference. Our reviewers—who are clinicians volunteering their time and expertise—evaluate each submission with great care. We ask all submitters to honor that commitment by adhering strictly to these guidelines.
Embargo Note: Abstracts chosen by the Scientific Selection Committee for First-to-Podium presentation are embargoed until the start of the session in which they are featured taking place on April 9, 2026.
2. Oral Presentation Only
Oral presentations will feature the highest-scoring abstracts. Primary contacts (submitter) of these abstracts will be notified of selection for Oral Presentation by the acceptance/decline deadline. Each oral abstract presenter will have 10 minutes to present key results of their research and for Q&A time. Abstracts selected for oral presentation will be notified individually. Oral presenters are also invited to present their abstract, in poster form, during the poster session if they desire.
3. Poster Presentation Only
Posters are exhibited in the Poster Hall on a bulletin board measuring 4 feet in height and 8 feet in width. The printed posters in the Poster Hall will be available for viewing during all Poster Hall hours. Digital ePosters will be available to view on multimedia screens placed throughout the conference space in the mobile app.
4. Poster Presentation if Not Selected for First-to-Podium or Oral Presentation
If a First-to-Podium Presentation Only or an Oral Presentation Only abstract is not chosen for an oral presentation, the abstract will be declined. If there is any chance you would like to be considered for Poster Presentation, if not accepted as First-to-Podium or Oral Presentation, select the following category during the submission process: Poster Presentation if Not Selected for First-to-Podium or Oral.
5. RAPID FIRE: Poster Talks
Selected poster presenters will give a 5-minute presentation of their poster including Q&A with the audience. Moderators will monitor questions from the audience after each presentation. The interaction is meant to be collegial, not critical, with the goal of attendees learning from the author’s experience and project. More information about RAPID FIRE: Poster Talks can be found here.
Abstract Submission Categories
- Case Series/Case Study
- Clinical Research
- Evidence-Based Practice
- Health Economics
- Laboratory Research
- Practice Innovation
Submitted abstracts will be reviewed and scored based upon the specific review criteria indicated for each of the respective submission category, as outlined: Submission Category Review Criteria.
Abstract Submission Instructions
All abstracts must be submitted electronically via the official SAWC Spring | WHS 2026 abstract submission portal website. Paper or e-mail abstract submissions will not be accepted.
Abstracts are brief summaries of the overall goal of an offering and the specific ideas or concepts that will be presented, including outcomes and implications for practice. Limit abstracts to a 250-to-350-word count and divide it into the following sections: introduction, methods, results, and discussion. An in-depth overview of the SAWC Spring | WHS 2026 Abstract Guidelines can be viewed here.
Key Dates* for Abstract Submissions
- Abstract Submission Site Opens – Tuesday, August 12, 2025
- Abstract Submission Site Closes – Friday, December 12, 2025
- Notification of Acceptance or Rejection – Wednesday, January 28, 2026
- Registration and Intent to Present Due – Wednesday, February 11, 2026
- PDF Posters Due – Wednesday, March 11, 2026
*Deadlines are tentative and subject to change
Abstracts submitted by December 12, 2025, may be eligible for the following benefits and/or awards that correspond to the selected abstract presentation categories indicated by the abstract submitter during the submission process:
- ePoster Display (digital poster PDF)
- Poster Hall Poster Display (printed poster)
- First-to-Podium Abstract presentation
- Marie Brown Etris Oral Abstract Awards
- Highest Scoring Abstract Awards (by Submission Category)
- Young Investigator Award
- RAPID FIRE: Poster Talks
- Tuition Support ($50 off registration fee for submitter)
- Publishing opportunities in supplement of Wounds
Abstract Presentation Categories
1. First-to-Podium Presentation Only
The First-to-Podium Presentation category is reserved exclusively for work that is being presented for the first time. Only truly original, practice-enhancing research, emerging data, or novel innovations that have not been presented, published, posted, or shared in any scientific, educational, or public forum are eligible for consideration.
To maintain the integrity of this high-visibility category and to respect the valuable time and expertise of our clinician reviewers, the following requirements will be enforced:
- Submissions must represent new and unpublished work.
- Content must not have been previously presented at any conference, symposium, webinar, or event etc.
- Content must not have been published in any journal, digital platform, or similar outlet.
- Submissions should include novel insights or innovative approaches with the potential to change or significantly enhance clinical practice.
Any submission entered into the First-to-Podium category that does not meet all eligibility criteria will be declined without an opportunity to resubmit.
This policy ensures fairness in the review process and upholds the standard of excellence expected by the conference. Our reviewers—who are clinicians volunteering their time and expertise—evaluate each submission with great care. We ask all submitters to honor that commitment by adhering strictly to these guidelines.
Embargo Note: Abstracts chosen by the Scientific Selection Committee for First-to-Podium presentation are embargoed until the start of the session in which they are featured taking place on April 9, 2026.
2. Oral Presentation Only
Oral presentations will feature the highest-scoring abstracts. Primary contacts (submitter) of these abstracts will be notified of selection for Oral Presentation by the acceptance/decline deadline. Each oral abstract presenter will have 10 minutes to present key results of their research and for Q&A time. Abstracts selected for oral presentation will be notified individually. Oral presenters are also invited to present their abstract, in poster form, during the poster session if they desire.
3. Poster Presentation Only
Posters are exhibited in the Poster Hall on a bulletin board measuring 4 feet in height and 8 feet in width. The printed posters in the Poster Hall will be available for viewing during all Poster Hall hours. Digital ePosters will be available to view on multimedia screens placed throughout the conference space in the mobile app.
4. Poster Presentation if Not Selected for First-to-Podium or Oral Presentation
If a First-to-Podium Presentation Only or an Oral Presentation Only abstract is not chosen for an oral presentation, the abstract will be declined. If there is any chance you would like to be considered for Poster Presentation, if not accepted as First-to-Podium or Oral Presentation, select the following category during the submission process: Poster Presentation if Not Selected for First-to-Podium or Oral.
5. RAPID FIRE: Poster Talks
Selected poster presenters will give a 5-minute presentation of their poster including Q&A with the audience. Moderators will monitor questions from the audience after each presentation. The interaction is meant to be collegial, not critical, with the goal of attendees learning from the author’s experience and project. More information about RAPID FIRE: Poster Talks can be found here.
Abstract Submission Categories
- Case Series/Case Study
- Clinical Research
- Evidence-Based Practice
- Health Economics
- Laboratory Research
- Practice Innovation
Submitted abstracts will be reviewed and scored based upon the specific review criteria indicated for each of the respective submission category, as outlined: Submission Category Review Criteria.
Abstract Submission Instructions
All abstracts must be submitted electronically via the official SAWC Spring | WHS 2026 abstract submission portal website. Paper or e-mail abstract submissions will not be accepted.
Embargo Policy for First-to-Podium Presentation Abstracts
Abstracts chosen by the Scientific Selection Committee for First-to-Podium presentation as part of the agenda/scientific program for the Symposium on Advanced Wound Care Spring | WHS are embargoed until the start of the session in which they are featured during the First to Podium Presentations session on April 9, 2026.
All First-to-Podium Presentation abstracts will be published to the Wounds website, the official journal of the Symposium on Advanced Wound Care following the meeting.
SAWC Spring | WHS Embargo Policy for First-to-Podium Presentation Abstracts
The Symposium on Advanced Wound Care (SAWC Spring | WHS) meeting follows a strict embargo policy to ensure the timely and accurate dissemination of scientific content. All abstract presenters, authors, Scientific Selection Committee and involved stakeholders must comply with the following guidelines to maintain the integrity of the conference and its communications.
1. Definition of "Embargoed" Content
"Embargoed content" refers to any abstract, research data, or findings presented at the SAWC Spring | WHS meeting that is identified as a First-to-Podium Presentation abstract. Such content is considered embargoed until the official embargo date is lifted by the meeting organizers.
2. Embargo Lift Date
Abstracts chosen by the Scientific Selection Committee for First-to-Podium presentation as part of the agenda/scientific program for the Symposium on Advanced Wound Care Spring | WHS are embargoed until the start of the session in which they are featured during the First-to-Podium Presentations session on April 9, 2026. This means no data, findings, or abstract details can be shared publicly (through press releases, social media, media interviews, or other public channels) until after the first oral presentation of the abstract at the meeting.
3. Restrictions on Public Disclosure
- Pre-Conference: Presenters and authors are prohibited from publicly sharing, presenting, or discussing abstract details, findings, or any related data prior to the official presentation at the SAWC Spring | WHS meeting.
- Post-Conference: Once the embargo is lifted (i.e., after the official presentation), authors and presenters may publicly disclose their work but must ensure accurate representation of the information presented during the meeting.
4. Media and Press Engagements
- Any media or press outreach regarding the content of First-to-Podium Presentation abstracts prior to the embargo lift date is strictly prohibited. All media representatives and journalists must adhere to this embargo policy.
- If there is any interest in discussing research or preliminary findings with the media, authors must coordinate through the SAWC Spring | WHS Press office or communication channels to ensure compliance.
- The embargo policy means that no news, information, results of any abstract, or research finding can be released to the media or published until the start of the session in which they are featured during the First to Podium Presentations session on April 9, 2026. This embargo includes revealing anything about the results (including the title of the abstract, since frequently the title indicates the finding) in a press release or “curtain raiser.” If you have questions, e-mail the SAWC Spring | WHS Press Team at pr@hmpglobal.com
5. Consequences of Embargo Violations
- Violation of the embargo policy will be taken seriously and may result in the withdrawal of the abstract from the conference or other sanctions, including disqualification from future participation in the conference.
- Authors, presenters, associated colleagues, Scientific Selection Committee members, members of the press, and members of the healthcare or financial industry found in violation of the embargo may also face restrictions on presenting at subsequent SAWC or affiliated events.
6. Additional Guidelines
- Authors as well as the Scientific Selection Committee should be aware that the embargo applies to all forms of public communication, including but not limited to social media posts, press releases, interviews, and publication in any media.
- Presenters are encouraged to consult with the conference organizers or the press team if they have questions or need clarification about the embargo policy.
7. General Inquiries
For any inquiries regarding this embargo policy or specific concerns related to abstract presentations, contact the SAWC Spring WHS Press Team at pr@hmpglobal.com.
Abstracts chosen by the Scientific Selection Committee for First-to-Podium presentation as part of the agenda/scientific program for the Symposium on Advanced Wound Care Spring | WHS are embargoed until the start of the session in which they are featured during the First to Podium Presentations session on April 9, 2026.
All First-to-Podium Presentation abstracts will be published to the Wounds website, the official journal of the Symposium on Advanced Wound Care following the meeting.
SAWC Spring | WHS Embargo Policy for First-to-Podium Presentation Abstracts
The Symposium on Advanced Wound Care (SAWC Spring | WHS) meeting follows a strict embargo policy to ensure the timely and accurate dissemination of scientific content. All abstract presenters, authors, Scientific Selection Committee and involved stakeholders must comply with the following guidelines to maintain the integrity of the conference and its communications.
1. Definition of "Embargoed" Content
"Embargoed content" refers to any abstract, research data, or findings presented at the SAWC Spring | WHS meeting that is identified as a First-to-Podium Presentation abstract. Such content is considered embargoed until the official embargo date is lifted by the meeting organizers.
2. Embargo Lift Date
Abstracts chosen by the Scientific Selection Committee for First-to-Podium presentation as part of the agenda/scientific program for the Symposium on Advanced Wound Care Spring | WHS are embargoed until the start of the session in which they are featured during the First-to-Podium Presentations session on April 9, 2026. This means no data, findings, or abstract details can be shared publicly (through press releases, social media, media interviews, or other public channels) until after the first oral presentation of the abstract at the meeting.
3. Restrictions on Public Disclosure
- Pre-Conference: Presenters and authors are prohibited from publicly sharing, presenting, or discussing abstract details, findings, or any related data prior to the official presentation at the SAWC Spring | WHS meeting.
- Post-Conference: Once the embargo is lifted (i.e., after the official presentation), authors and presenters may publicly disclose their work but must ensure accurate representation of the information presented during the meeting.
4. Media and Press Engagements
- Any media or press outreach regarding the content of First-to-Podium Presentation abstracts prior to the embargo lift date is strictly prohibited. All media representatives and journalists must adhere to this embargo policy.
- If there is any interest in discussing research or preliminary findings with the media, authors must coordinate through the SAWC Spring | WHS Press office or communication channels to ensure compliance.
- The embargo policy means that no news, information, results of any abstract, or research finding can be released to the media or published until the start of the session in which they are featured during the First to Podium Presentations session on April 9, 2026. This embargo includes revealing anything about the results (including the title of the abstract, since frequently the title indicates the finding) in a press release or “curtain raiser.” If you have questions, e-mail the SAWC Spring | WHS Press Team at pr@hmpglobal.com
5. Consequences of Embargo Violations
- Violation of the embargo policy will be taken seriously and may result in the withdrawal of the abstract from the conference or other sanctions, including disqualification from future participation in the conference.
- Authors, presenters, associated colleagues, Scientific Selection Committee members, members of the press, and members of the healthcare or financial industry found in violation of the embargo may also face restrictions on presenting at subsequent SAWC or affiliated events.
6. Additional Guidelines
- Authors as well as the Scientific Selection Committee should be aware that the embargo applies to all forms of public communication, including but not limited to social media posts, press releases, interviews, and publication in any media.
- Presenters are encouraged to consult with the conference organizers or the press team if they have questions or need clarification about the embargo policy.
7. General Inquiries
For any inquiries regarding this embargo policy or specific concerns related to abstract presentations, contact the SAWC Spring WHS Press Team at pr@hmpglobal.com.
Notification and Terms of Acceptance
Acceptance and Correspondence
Primary Contact
All abstract communications will be sent to the primary contact (submitter). The primary contact will be responsible for notifying all authors of important details and deadlines. Make sure to save abstractsubmissions@hmpglobal.com to your address book so that you do not miss important correspondences. Additionally, the website will be updated with any important dates or instructions.
We are not responsible for any e-mails that are not received due to misspellings, defunct e-mail accounts, or e-mails blocked from abstractsubmissions@hmpglobal.com.
Disposition/Notification of Acceptance
Abstracts will be accepted on a competitive basis. The acceptance/rejection or waitlist notification e-mail will be sent to the primary contact (submitter). Do not inquire about the status of your submission before the date noted at the top of this page, as no further information will be available. Prior to the meeting, all information will be forwarded to the primary contact only and they are responsible for notifying all the other authors of upcoming details.
Intent to Present
SAWC | WHS 2026 requires proof of pre-registration for all accepted abstract presenters. After registering, it is the designated primary contact’s responsibility to mark his/her intent to present through the abstract portal, as outlined in the acceptance e-mail, by providing the badge number of the registered representative. The badge number can be found on your registration confirmation. Instructions on this process will be included in your acceptance e-mail. Even though you may be registered for the meeting, intent to present must still be submitted. If the intent to present is not submitted by the date included in your acceptance e-mail, the abstract will be withdrawn.
Important Links
Click below for information on:
- Abstract Embargo Policy
- Frequently Asked Questions
- Presentation Categories
- Review Criteria
- Submission Guidelines
- Poster Presentation Information
It’s important to note that expenses associated with the submission and presentation of an abstract are the responsibility of the presenter and may include hotel, travel, and meeting registration.
All poster presenters are responsible for the cost and organization of printing, shipment, display of and removal of their printed posters in the Poster Hall during specified time. The meeting does not provide these services.
Questions?
Review the below additional documents in the 'Important Links' section above before contacting the SAWC Abstract Team with questions. If there are questions not answered in the above documents, e-mail abstractsubmissions@hmpglobal.com.
Acceptance and Correspondence
Primary Contact
All abstract communications will be sent to the primary contact (submitter). The primary contact will be responsible for notifying all authors of important details and deadlines. Make sure to save abstractsubmissions@hmpglobal.com to your address book so that you do not miss important correspondences. Additionally, the website will be updated with any important dates or instructions.
We are not responsible for any e-mails that are not received due to misspellings, defunct e-mail accounts, or e-mails blocked from abstractsubmissions@hmpglobal.com.
Disposition/Notification of Acceptance
Abstracts will be accepted on a competitive basis. The acceptance/rejection or waitlist notification e-mail will be sent to the primary contact (submitter). Do not inquire about the status of your submission before the date noted at the top of this page, as no further information will be available. Prior to the meeting, all information will be forwarded to the primary contact only and they are responsible for notifying all the other authors of upcoming details.
Intent to Present
SAWC | WHS 2026 requires proof of pre-registration for all accepted abstract presenters. After registering, it is the designated primary contact’s responsibility to mark his/her intent to present through the abstract portal, as outlined in the acceptance e-mail, by providing the badge number of the registered representative. The badge number can be found on your registration confirmation. Instructions on this process will be included in your acceptance e-mail. Even though you may be registered for the meeting, intent to present must still be submitted. If the intent to present is not submitted by the date included in your acceptance e-mail, the abstract will be withdrawn.
Important Links
Click below for information on:
- Abstract Embargo Policy
- Frequently Asked Questions
- Presentation Categories
- Review Criteria
- Submission Guidelines
- Poster Presentation Information
It’s important to note that expenses associated with the submission and presentation of an abstract are the responsibility of the presenter and may include hotel, travel, and meeting registration.
All poster presenters are responsible for the cost and organization of printing, shipment, display of and removal of their printed posters in the Poster Hall during specified time. The meeting does not provide these services.
Questions?
Review the below additional documents in the 'Important Links' section above before contacting the SAWC Abstract Team with questions. If there are questions not answered in the above documents, e-mail abstractsubmissions@hmpglobal.com.
Back to top